Data as of Sep 16
| -0.05 / -0.37%|
The 4 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 18.50, with a high estimate of 22.00 and a low estimate of 17.00. The median estimate represents a +37.85% increase from the last price of 13.42.
The current consensus among 4 polled investment analysts is to Buy stock in AngioDynamics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.